Research.Patient.info
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE3
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM
This study looks at a new medicine called aficamten for non-obstructive hypertrophic cardiomyopathy (nHCM). It compares aficamten to a dummy medicine (placebo) to see if it improves quality of life, exercise ability, and overall health in adults with nHCM.
United States · Argentina · Australia - ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Multi-Center, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
This study is testing a new tablet, Aficamten, for people with a heart condition called non-obstructive hypertrophic cardiomyopathy. It compares Aficamten to a dummy pill to see if it improves how people feel and their exercise ability.
Poland · Spain · Italy